| The therapeutic and diagnostic role of exosomes in cardiovascular diseases P Zamani, N Fereydouni, AE Butler, JG Navashenaq, A Sahebkar Trends in cardiovascular medicine 29 (6), 313-323, 2019 | 147 | 2019 |
| Therapeutic use of curcumin‐encapsulated and curcumin‐primed exosomes MN Oskouie, NS Aghili Moghaddam, AE Butler, P Zamani, A Sahebkar Journal of cellular physiology 234 (6), 8182-8191, 2019 | 103 | 2019 |
| Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy P Zamani, AA Momtazi‐Borojeni, ME Nik, RK Oskuee, A Sahebkar Journal of cellular physiology 233 (7), 5189-5199, 2018 | 79 | 2018 |
| Association of hematocrit with blood pressure and hypertension M Emamian, SM Hasanian, M Tayefi, M Bijari, F Movahedian far, ... Journal of clinical laboratory analysis 31 (6), e22124, 2017 | 66 | 2017 |
| MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer P Zamani, JG Navashenaq, AR Nikpoor, M Hatamipour, RK Oskuee, ... Journal of controlled release 303, 223-236, 2019 | 61 | 2019 |
| Comparison of honey and dextrose solution on post-operative peritoneal adhesion in rat model VB Rahimi, R Shirazinia, N Fereydouni, P Zamani, S Darroudi, ... Biomedicine & Pharmacotherapy 92, 849-855, 2017 | 60 | 2017 |
| Anti-Epcam aptamer (Syl3c)-functionalized liposome for targeted delivery of doxorubicin: In vitro and in vivo antitumor studies in mice bearing C26 colon carcinoma M Mashreghi, P Zamani, SA Moosavian, MR Jaafari Nanoscale Research Letters 15, 1-13, 2020 | 58 | 2020 |
| Crosstalk in cancer resistance and metastasis S Norouzi, MG Valokala, F Mosaffa, MR Zirak, P Zamani, J Behravan Critical Reviews in Oncology/Hematology 132, 145-153, 2018 | 57 | 2018 |
| MicroRNAs as important regulators of the NLRP3 inflammasome P Zamani, RK Oskuee, SL Atkin, JG Navashenaq, A Sahebkar Progress in biophysics and molecular biology 150, 50-61, 2020 | 53 | 2020 |
| Evaluation of the effects of Iranian propolis on the severity of post operational-induced peritoneal adhesion in rats VR Askari, VB Rahimi, P Zamani, N Fereydouni, P Rahmanian-Devin, ... Biomedicine & Pharmacotherapy 99, 346-353, 2018 | 53 | 2018 |
| Preparation and characterization of stable nanoliposomal formulations of curcumin with high loading efficacy: in vitro and in vivo anti-tumor study M Karimi, F Gheybi, P Zamani, M Mashreghi, S Golmohammadzadeh, ... International journal of pharmaceutics 580, 119211, 2020 | 51 | 2020 |
| Oxidative stress and inflammation, two features associated with a high percentage body fat, and that may lead to diabetes mellitus and metabolic syndrome S Darroudi, N Fereydouni, M Tayefi, M Ahmadnezhad, P Zamani, B Tayefi, ... BioFactors 45 (1), 35-42, 2019 | 45 | 2019 |
| Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer P Zamani, M Teymouri, AR Nikpoor, JG Navashenaq, Z Gholizadeh, ... European Journal of Cancer 129, 80-96, 2020 | 38 | 2020 |
| Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma P Zamani, M Matbou Riahi, AA Momtazi-Borojeni, K Jamialahmadi Artificial Cells, Nanomedicine, and Biotechnology 46 (7), 1301-1313, 2018 | 33 | 2018 |
| Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor … P Zamani, JG Navashenaq, M Teymouri, M Karimi, M Mashreghi, ... Life sciences 252, 117646, 2020 | 32 | 2020 |
| Doxil chemotherapy plus liposomal P5 immunotherapy decreased myeloid-derived suppressor cells in murine model of breast cancer JG Navashenaq, P Zamani, AR Nikpoor, J Tavakkol-Afshari, MR Jaafari Nanomedicine: Nanotechnology, Biology and Medicine 24, 102150, 2020 | 31 | 2020 |
| Cell cytotoxicity, immunostimulatory and antitumor effects of lipid content of liposomal delivery platforms in cancer immunotherapies. A comprehensive in-vivo and in-vitro study AR Nikpoor, MR Jaafari, P Zamani, M Teymouri, H Gouklani, E Saburi, ... International journal of pharmaceutics 567, 118492, 2019 | 28 | 2019 |
| Targeted‐nanoliposomal combretastatin A4 (CA‐4) as an efficient antivascular candidate in the metastatic cancer treatment ME Nik, AA Momtazi‐Borojeni, P Zamani, JG Navashenaq, M Iranshahi, ... Journal of Cellular Physiology 234 (9), 14721-14733, 2019 | 23 | 2019 |
| Association between serum zinc and copper levels and antioxidant defense in subjects infected with human T-lymphotropic virus type 1 S Abolbashari, S Darroudi, M Tayefi, Z Khashyarmaneh, P Zamani, ... Journal of blood medicine, 29-35, 2018 | 21 | 2018 |
| The therapeutic potential of targeting CD73 and CD73-derived adenosine in melanoma A Soleimani, HK Farshchi, F Mirzavi, P Zamani, A Ghaderi, Y Amini, ... Biochimie 176, 21-30, 2020 | 19 | 2020 |
Mahmoud Reza JaafariProf. of Pharmaceutics and Pharmaceutical NanotechnologyVerified email at mums.ac.ir
